ArticleCancer medicine2021

Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non-small cell lung cancer patients.

Hang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.